Histological difference between complete responders and nonresponders to interferon therapy of the livers of patients with chronic hepatitis C

Pathology International

Volumn 43, Issue 5, 1993, Pages 230-236

  Uchida, Toshikazu ^a   Taira, Masaaki ^a   Shikata, Toshio ^a   Moriyama, Mitsuhiro ^a   Tanaka, Naohide ^a   Okubo, Hitoshi ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic hepatitis; hepatitis C; interferon; liver histology; viral hepatitis

Indexed keywords

INTERFERON;

ADULT; ARTICLE; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE;

ADULT; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; HEPATITIS C; HUMAN; INTERFERONS; LIVER; MALE; MIDDLE AGE; TREATMENT OUTCOME;

EID: 0027192163     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1993.tb01137.x     Document Type: Article

References (18)

1. Chronic non‐A, non‐B hepatitis developed after transfusions, illicit self‐injections or sporadically. Outcome during lone‐term follow‐up—a comparison
2. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
3. Prevalence of anti‐HCB anitbody in blood donors in the Tokyo area
4. Prevalence of antibody angainst the core protein of hepatitis C virus in patients with hepatocellular carcdinoma
5. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
6. An assay for circulating antibodies to a major etilolgic virus of human non‐A, non‐B hepatitis
7. Detection of hepatitis C virus RNA by a two‐stage polymerase chain reaction with two pairs of primers deduced from the 5'‐noncoding region
8. Improved detection of hepatitis C virus antibodies in high‐risk populations
9. Treatment of chronic non‐A, non‐B hepatitis with recombinant human alpha interferon. A perliminary report
10. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial
11. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double‐blind, placebo‐controlled trial
12. Interferon in viral hepatitis: Role in pathogenesis and treatment
13. Recombinant leukocyte interferon treatment of chronic hepatitis B
14. Treatment of chronic hepatitis due to hepatitis B virus
15. Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis
16. Detection of hepatitis C virus RNA is serum of patients with chronic hepatitis C treated with interferon‐α
17. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources
18. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsveness to interferon therapy in viremic patients